IQIRVO

ELAFIBRANOR · Ipsen Biopharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for IQIRVO, covering 2024-06-10 to 2026-08-07. Get the full timeline:

Most recent: FDA Approved: IQIRVO — Supplemental Application (Ipsen Biopharmaceuticals, Inc.)